Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis

Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

(2016) Vidmantas Petraitis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy

(2016) Luc J. Huurneman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints

(2016) Laura L. Kovanda et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamics of Amphotericin B Deoxycholate, Amphotericin B Lipid Complex, and Liposomal Amphotericin B against Aspergillus fumigatus

(2015) Zaid Al-Nakeeb et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of Isavuconazole in a DynamicIn VitroModel of Invasive Pulmonary Aspergillosis

(2015) Helen Box et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis

(2015) Ruta Petraitiene et al.   MEDICAL MYCOLOGY

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis

(2015) Dionysios Neofytos et al.   PLoS One

Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in anIn VitroPharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum

(2014) A. Elefanti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity

(2014) Michael J. Dolton et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model--authors' response

(2014) M. Siopi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Micafungin for the treatment of invasive aspergillosis

(2014) D.A. Enoch et al.   JOURNAL OF INFECTION

Serum and urine galactomannan testing for screening in patients with hematological malignancies

(2014) W. Duettmann et al.   MEDICAL MYCOLOGY

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

(2014) Louis Yi Ann Chai et al.   PLoS One

Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing

(2014) Marcio Nucci et al.   PLoS One

Single-Dose Pharmacodynamics of Amphotericin B against Aspergillus Species in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2013) Rafal Al-Saigh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

MIC Values of Voriconazole Are Predictive of Treatment Results in Murine Infections by Aspergillus terreus Species Complex

(2013) Valentina Salas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole resistance in Aspergillus fumigatus

(2013) Edith Vermeulen et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Electronic Nose Technology for Detection of Invasive Pulmonary Aspergillosis in Prolonged Chemotherapy-Induced Neutropenia: a Proof-of-Principle Study

(2013) K. de Heer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pharmacodynamics of Itraconazole against Aspergillus fumigatus in anIn VitroModel of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration

(2012) Zaid Al-Nakeeb et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of Voriconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis: Implications for In Vitro Susceptibility Breakpoints

(2012) Adam R. Jeans et al.   JOURNAL OF INFECTIOUS DISEASES

Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a NewIn VitroPharmacokinetic/Pharmacodynamic Model

(2011) Joseph Meletiadis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition

(2011) S. A. Nouer et al.   CLINICAL INFECTIOUS DISEASES

Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay

(2011) A. M. Tortorano et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy

(2011) Susan J. Howard et al.   JOURNAL OF INFECTIOUS DISEASES

The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1->3)- -D-Glucan, and Consequences of Delayed Antifungal Therapy

(2010) W. W. Hope et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

(2010) R Herbrecht et al.   BONE MARROW TRANSPLANTATION

Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

(2010) S. Koo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)- -D-glucan detection in serum samples as an adjunct to diagnosis

(2010) E. Mokaddas et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene

(2009) E. Mavridou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

(2009) Johan Maertens et al.   CANCER

Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis

(2008) C. R. Thornton   Clinical and Vaccine Immunology

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications

(2008) Marisa H. Miceli et al.   CLINICAL INFECTIOUS DISEASES

Liposomal amphotericin B: what is its role in 2008?

(2008) F. Lanternier et al.   CLINICAL MICROBIOLOGY AND INFECTION

Conventional or molecular measurement ofAspergillusload

(2008) K. V. Clemons et al.   MEDICAL MYCOLOGY